Dr. Mark W. Feinberg is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH) and an associate professor of medicine at Harvard Medical School (HMS). In addition, he is an affiliated faculty member at the Harvard Stem Cell Institute.
Dr. Feinberg received his medical degree from the Medical College of Pennsylvania. He completed an internal medicine residency at Duke University Medical Center. He then completed two cardiology fellowships: a research fellowship at Harvard School of Public Health and a clinical fellowship at BWH. Dr. Feinberg is board certified in internal medicine and cardiology.
Dr. Feinberg’s clinical interests include noninvasive clinical cardiology, vascular medicine, and cardiovascular disease prevention. Dr. Feinberg directs a basic science laboratory that investigates mechanisms leading to the development of atherosclerosis (coronary artery disease) and myocardial infarction (heart attack). These studies have revealed novel and unexpected pathophysiological roles for microRNAs and transcriptional regulators in vascular inflammation and repair, with therapeutic implications for ischemic cardiovascular disease and other acute and chronic inflammatory diseases. Dr. Feinberg has held various leadership roles in cardiovascular research including his service on national peer review study sections, editorial service, and as a Co-Chair of the Brigham Research Institute’s CVDM Center.
